Skip to main content

Table 2 Kaplan-Meier analysis for overall survival rate of patients with gliomas

From: Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro

Characteristics Mean survival time (months) 95% confidence interval (months) P values*
Age (years)    
<47 (n = 37) 33.98 ± 3.67 26-41 0.324
≥47 (n = 39) 26.63 ± 3.16 20-32  
Gender    
Male (n = 52) 31.46 ± 3.09 25-37 0.985
Female (n = 24) 25.92 ± 3.41 19-32  
Histological grade    
High grade (WHO III-IV) (n = 41) 13.61 ± 1.47 10-16 0.001
Low grade (WHO I-II) (n = 35) 52.45 ± 2.31 47-56  
Tumor recurrence    
No (n = 57) 30.49 ± 3.01 24-36 0.672
Yes (n = 19) 30.42 ± 4.13 22-38  
HGF expression    
High expression (n = 45) 21.46 ± 2.93 15-27 0.001
Low expression (n =31) 43.67 ± 3.04 37-49  
Cell proliferation    
High PI (n = 43) 14.41 ± 1.60 11-17 0.001
Low PI (n = 33) 53.44 ± 2.13 49-57  
Intratumoral microvessel density    
≥ Mean IMD value (n = 27) 24.46 ± 4.05 16-32 0.079
< Mean IMD value (n = 49) 34.55 ± 3.13 28-40  
  1. *Log rank test.